“…More than 40 different pathogenic mutations within the gene encoding TDP43 ( TARDBP ) underlie familial ALS, FTD, or both ( Barmada and Finkbeiner, 2010 ). Disease-associated TARDBP mutations elicit gain-of-function toxicity by interfering with TDP43 autoregulation ( White et al, 2018 ; Fratta et al, 2018 ; Koyama et al, 2016 ), enhancing cytoplasmic TDP43 mislocalization and deposition, and affecting TDP43 clearance ( Barmada et al, 2010 , 2014 ; Nishimura et al, 2014 ; Watanabe et al, 2013 ; Ling et al, 2010 ). Supporting the link between TDP43 turnover and neurodegeneration, toxicity is directly proportional to TDP43 abundance in individual neurons, and accelerating TDP43 turnover extends neuronal survival and mitigates disease phenotypes in disease models ( Barmada et al, 2014 ).…”